Evidence map›Paper›PMID 40949067›Full record

ArticleCureus2025

Primary Signet Ring Cell Carcinoma of the Lung: A Rare Histologic Variant With Distinct Radiologic Presentation.

Najlae Demnati Sadki, Ouiame El Meliani, Hind Majd, Mohammed Tarik Saoudi, Kaoutar Maadin, Abdelilah Khallaf, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi and 2 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Najlae Demnati SadkiMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Ouiame El MelianiMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Hind MajdMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Mohammed Tarik SaoudiMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Kaoutar MaadinMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Abdelilah KhallafDiagnostic Radiology, Hassan II University Hospital of Fez, Fez, MAR.
Lamiae AmaadourMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Karima OuallaMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Zineb BenbrahimMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Samia ArifiMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Nawfel MellasMedical Oncology, Hassan II University Hospital of Fez, Fez, MAR.
Mustapha MaaroufiDiagnostic Radiology, Hassan II University Hospital of Fez, Fez, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signet ring cell carcinoma (SRCC) is a rare and distinct subtype of adenocarcinoma. It can arise in various organs, including the stomach, colon, breast, bladder, and prostate. It may also occur as a primary pulmonary tumor. We report a case of a 65-year-old woman with no significant medical history, who presented with a two-month history of dyspnea and hemoptysis, associated with weight loss. A chest CT scan revealed a locally advanced pulmonary mass with mediastinal lymphadenopathy and bilateral pulmonary metastases. A biopsy was performed and confirmed a diagnosis of pulmonary-origin signet ring cell adenocarcinoma. Given the patient's general condition, chemotherapy with weekly paclitaxel and carboplatin (AUC2) was initiated. At the first evaluation after three cycles, the disease was stable. The patient subsequently developed a respiratory infection due to a multidrug-resistant organism, and despite appropriate antibiotic therapy, she passed away because of the infection. Primary SRCC of the lung remains a diagnostic and therapeutic challenge, with poor prognosis despite early intervention. The rapid clinical decline observed in this case highlights the aggressive nature of the disease and the importance of supportive care.

Indexed as

cancer prognosischemotherapy responselung cancer with gastrointestinal featuresprimary metastatic lung tumorsignet-ring cell carcinoma

Identifiers

PMID40949067
PMCPMC12425150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.